Jianjun Qu
Papers
1
Total Citations
4
H-Index
1
About
Jianjun Qu is a leading researcher in gastrointestinal oncology, with a primary focus on optimizing surgical outcomes for gastric cancer patients. His work centers on the intersection of neoadjuvant chemotherapy, minimally invasive surgery, and perioperative care. Dr. Qu’s major contribution is the design and leadership of the GISSG2023-01 Study, a multicenter randomized controlled trial investigating the effect of perioperative probiotic supplements on short-term clinical outcomes following laparoscopic or robotic radical gastrectomy. This study addresses a critical gap in managing patients with advanced gastric cancer who undergo neoadjuvant chemotherapy, aiming to mitigate postoperative complications and improve recovery. The protocol paper for this trial has already garnered 4 citations since its 2025 publication, signaling its immediate impact on the field. By rigorously evaluating the role of gut microbiota modulation in surgical recovery, Dr. Qu is pioneering evidence-based strategies to enhance the safety and efficacy of complex gastrectomies. His work is particularly notable for integrating cutting-edge robotic surgery with nutritional interventions, reflecting a holistic approach to cancer care. For students and researchers, Dr. Qu’s research exemplifies how well-designed clinical trials can translate into tangible improvements in patient outcomes.
Research Focus
Key Achievements
Top Papers
- 1